B cells expressing CD20 are killed via anti-CD20 antibody binding that triggers Fc gamma RIIIa–mediated ADCC by NK cells, antibody-dependent phagocytosis, and direct type II cell death (with relatively reduced complement-mediated cytotoxicity).